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Abstract 
BACKGROUND AND AIM: Giant cell lesions as a group of the oral and maxillofacial lesions are common and potentially 
destructive. The aim of this study was to assess the frequency of oral lesions containing giant cells in a 22-year period 
in Isfahan Dental School, Iran. 
METHODS: In this epidemiological, cross-sectional, retrospective study the archive information in the Department of 
Oral Pathology, School of Dentistry between 1991 and 2012 was used. All information obtained from the patients 
records with giant cell lesions [peripheral giant cell granuloma (PGCG), central giant cell granuloma (CGCG), 
aneurysmal bone cyst, and Cherubism and Brown tumor] were analyzed using SPSS, chi-square test and Fisher  
(P < 0.050). 
RESULTS: Of the 8217 cases with pathology records, 591 cases (7.1%) were giant cell lesions. The most common lesion 
was PGCG (68.5%). The prevalence of lesions in the mandible was more than the maxilla (P = 0.039), and also the 
prevalence of these lesions in woman was slightly more than men (P = 0.078). 
CONCLUSION: The giant cell lesions were more common in women and in the mandible. They were seen more 
frequently in the second decade of life. Regards the results of this study, we can prevent PGCG using methods such as 
improvement of oral hygiene. 
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nowledge of clinical epidemiology 
and clinical features of lesions can 
lead to early diagnosis and proper 
control of each lesion. This could be 
avoided the affected areas from further 
damages. Giant cell lesions are some of the 
potentially destructive oral jaw lesions which 
have shown significant outbreak in various 
studies.1 Giant cell lesions of the jaws were 
separated from other jaw lesions by Jaffe2 
when they were termed “giant cell reparative 
granulomas.”1 These lesions which show 
multinucleated giant cells in histopathologic 
features composed of central giant cell 
granuloma (CGCG), peripheral giant cell 
granuloma (PGCG), giant cell tumor (GCT), 
aneurysmal bone cysts (ABC), brown tumors 
associated with hyperparathyroidism and 
Cherubism disease.1 
Katsikeri et al.3 have reported PGCG was 
more prevalent in the fourth to sixth decades 
of life and in females. Some researchers 
believe that this lesion can cause by local 
irritation factors such as improper prosthesis 
and accumulation of plaque.4-6 Neville et al.7 
discussed a wide age range for this lesion 
K 
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from first to sixth decades of life. The mean 
age of the patients ranged from 31 to 41 years 
in several extensive reviews, and this lesion 
has been reported in females.7 
In one study, incidence of CGCG was 
estimated 0.001% in the general population8 
and Jadu et al.9 showed 60% of cases occur 
before age 30. Gungormus and Akgul10 in a 
study reported that CGCG has been occurred 
in 89% of cases before the age of 40% and 
78% of cases presented in females.  
ABC, at first, was described by Jaffe and 
Lichtenstein.11 It is an uncommon lesion 
which in a 20-year study only 17 cases have 
been reported.12 Cherubism is a rare non-
neoplastic genetically inherited disease and 
tends to involve the mandible more than 
maxilla.13 
In a study have been carried out by 
Mohajerani et al.14 in the central-northern 
part of Iran, giant cell lesions were most 
frequently diagnosed among females, in the 
2nd and 3rd decade of life and in the anterior 
part of the mandible. In this study, PCGC is 
the most common giant cell lesion in both 
jaws and ABC showed the lowest prevalence 
(1.4%) among these lesions. 
The prevalence of these lesions showed a 
wide variation which results from differences 
in population groups, styles of life and some 
other clinical factors.6 The most studies have 
examined each of the giant cell lesions 
separately.5,6 Therefore, to achieve the unique 
and specific result more extensive studies in 
different geographic regions are required. 
This study aimed to evaluate the 
frequency and demographic specifications of 
oral and maxillofacial lesions containing 
giant cells in the central part of Iran (Isfahan). 
Methods 
This study is a cross-sectional study (Ethical 
Committee Number: 293011) and has been 
reported descriptively. Sampling was done 
using available data (Existing data), from 
Department of Oral and Maxillofacial 
Pathology, School of Dentistry, Isfahan 
University of Medical Sciences. All patients 
were assessed during 1991-2012. 
Available records of giant cells lesions 
(PGCG, CGCG, ABC, Cherubism and Brown 
tumor) from diagnostic reports were 
collected. Name of the lesion and patients 
information including age, gender, and 
location of the lesion were assessed. Records 
that were incomplete and did not have the 
necessary clinical information were excluded. 
All microscopic slides (H and E staining) 
were reviewed by two pathologists 
simultaneously to confirm the diagnosis. The 
information was analyzed using SPSS 
software (version 19, SPSS Inc., Chicago, IL, 
USA), chi-square test and Fisher’s exact test 
(P < 0.050). 
Results 
Among the 8217 pathologic records in the 
Isfahan Oral and Maxillofacial Pathology 
Department, 635 cases were giant cell lesions. 
Among these, 44 cases were excluded due to 
incomplete clinical information and 591 cases 
were analyzed.  
The most frequent lesion was PGCG 
(68.5%). The frequency distribution of the 
lesions was shown in table 1. 
 
Table 1. The frequency of giant cell lesions 
The type of lesion n (%) 
PGCG 405 (68.5) 
CGCG 168 (28.4) 
ABC 12 (2.0) 
Cherubism 2 (0.3) 
Brown tumor 4 (0.7) 
Total 591 (100) 
CGCG: Central giant cell granuloma; PGCG: 
Peripheral giant cell granuloma; ABC: Aneurysmal 
bone cysts 
 
In table 2, the dispensation of the lesions 
according to gender has been shown. The 
data showed that 47.7% of males and 52.3% 
of females had PGCG. The difference 
between males and females was not 
significant (P = 0.051). In CGCG group (the 
second most frequent lesion), respectively, 
37.5% of the patients were males and 62.5% 
were females, and the differences between 
them were significant (P = 0.001). The 
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frequency of ABC was not statistically 
significant differences among males and 
females with chi-square test (P = 0.378). 
 
Table 2. Frequency of giant cell lesions based  
on gender 
Type of lesion 
Gender 
Male  
[n (%)] 
Female  
[n (%)] 
Total  
[n (%)] 
PGCG 193 (47.7) 212 (52.3) 405 (68.5) 
CGCG 63 (37.5) 105 (62.5) 168 (28.4) 
ABC 7 (58.3) 5 (41.7) 12 (2.0) 
Cherubism 1 (50.0) 1 (50.0) 2 (0.3) 
Brown tumor 3 (75.0) 1 (25.0) 4 (0.7) 
Total 267 (45.2) 324 (54.8) 591 (100) 
P ≤ 0.050 was considered significant.  
CGCG: Central giant cell granuloma; PGCG: Peripheral 
giant cell granuloma; ABC: Aneurysmal bone cysts 
 
The highest incidence rate of giant cell 
lesions was in the second decade of life, 
although the most common lesion; PGCG; 
showed the highest incidence in the fifth 
decade. One case of Cherubism in the first 
decade of life and another one in the third 
decade of life were seen. The distribution of 
other lesions can be seen in table 3. 
According to table 4, 63.3% and 36.7% of 
the lesions were seen in the upper and lower 
jaw, respectively. The differences between 
these were significant (P = 0.039). 
Discussion 
The data of this study showed that the most 
common giant cells lesion was, PGCG, 
similar to the study conducted by Tandon et 
al.15 and Gümüşok et al.16 In contrast, 
Mullapudi et al.17 showed that CGCG s 
constituted the majority of giant cell lesions. 
This reactive hyperplastic benign lesion 
usually occurred due to local trauma and 
originated from tooth periodontal fibers or 
mucoperiosteum.18 Chatherine said that the 
highest incidence of this lesion was seen in 
age range 41-50 years. Then, the most 
common age of onset were the first and 
fourth decades of life. Reactive lesions such 
as PGCG, when occurred in children can 
growth rapidly and within a few months 
reach to substantial size, interfering with the 
eruption of the teeth and cause bone 
resorption. Early detection of these lesions 
leads to a more conservative surgical 
approach and create a lower risk for tooth 
and supporting bone.19 
In the present study, the prevalence of 
PGCG was nearly equal in the two genders; 
this finding is consistent with a number of 
earlier studies.17,20,21 In contrast, Salum et al.22 
and Zhang et al.23 showed the incidence of 
this lesion was higher in male. The reason of 
this difference could be explained by 
different population groups.  
In this study, these lesions are more 
common in the mandible, which is consistent 
with the results of other studies.17,20,24,25 
According to these results, PGCG as the most 
common lesion contained giant cell have 
equal incidence in both genders and its 
prevalence was higher in the fifth decade of 
life and in the mandible. Environmental 
factors which caused this lesion such as 
calculus, dental plaque, and others irritating 
factors could indicate poor oral health status 
in the population study.  
 
Table 3. Frequency of giant cell lesion based on age 
Age (year) 
Lesion 
PGCG 
[n (%)] 
CGCG  
[n (%)] 
ABC  
[n (%)] 
Cherubism  
[n (%)] 
Brown tumor  
[n (%)] 
Total  
[n (%)] 
0-10 67 (16.5) 20 (11.9) 2 (16.7) 1 (50.0) 0 (0) 90 (15.2) 
11-20 45 (11.1) 70 (41.7) 7 (58.3) 0 (0) 4 (100) 126 (21.3) 
21-30 48 (11.9) 23 (13.7) 2 (16.7) 1 (50.0) 0 (0) 74 (12.5) 
31-40 69 (17.0) 25 (14.9) 0 (0) 0 (0) 0 (0) 94 (15.9) 
41-50 86 (21.2) 11 (6.5) 0 (0) 0 (0) 0 (0) 97 (16.4) 
51-60 60 (14.8) 12 (7.1) 1 (8.3) 0 (0) 0 (0) 73 (12.4) 
61-70 30 (7.4) 7 (4.2) 0 (0) 0 (0) 0 (0) 37 (6.3) 
Total 405 (68.5) 168 (28.4) 12 (2.0) 2 (0.3) 4 (0.7) 591 (100) 
P ≤ 0.050 was considered significant.  
CGCG: Central giant cell granuloma; PGCG: Peripheral giant cell granuloma; ABC: Aneurysmal bone cysts 
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Table 4. Frequency of giant cell lesion based on 
location of lesion 
Lesion 
Location 
Maxilla  
[n (%)] 
Mandible 
[n (%)] 
Total  
[n (%)] 
PGCG 152 (37.5) 253 (62.5) 405 (68.5) 
CGCG 63 (37.5) 105 (62.5) 168 (28.4) 
ABC 0 (0) 12 (100) 12 (2.0) 
Cherubism 1 (50.0) 1 (50.0) 2 (0.3) 
Brown tumor 1 (25.0) 3 (75.0) 4 (0.7) 
Total 217 (36.7) 374 (63.3) 591 (100) 
P ≤ 0.050 was considered significant.  
CGCG: Central giant cell granuloma; PGCG: Peripheral 
giant cell granuloma; ABC: Aneurysmal bone cysts 
 
The second most common lesion in this 
study is the CGCG. This benign bone lesion 
was described by Jaffe for the first time in 
1935.2 The clinical behaviors of these lesions 
show a significant difference, occasionally 
they are asymptomatic lesions and usually 
detected on routine physical examination. 
Sometimes these lesions have been diagnosed 
with rapid onset, pain, paresthesia, root 
resorption, and teeth divergence.20 
In this study, the most patients with 
CGCG were females that significant 
differences were found in comparison with 
males. This finding is consistent with 
previous results,7,20 and some studies have 
been shown this frequency two times greater 
in females.9,20 The prevalence of these lesions 
was higher in the second decade of life. It is 
also in close agreement with previous 
studies.9,20,21 Mullapudi et al.17 showed CGCG 
was the most common oral and maxillofacial 
giant cell lesion and a history of trauma can 
be ascertained. In previous studies, the 
incidence of CGCG was higher in the 
mandible which is consistent with the results 
of the present study.7,9,21,26,27 
The third lesion in view of incidence in 
this study is the ABC with 12 cases (2%). In a 
similar study, this prevalence is reported 
1.39%14 and in a separate study conducted in 
China, the prevalence of ABC for a period of 
20-year were recorded 17 cases.28 Several 
theories have been suggested for the etiology 
of this lesion. In 1978, Hillerup and Hjorting-
Hansen29 suggested that ABC, simple bone 
cyst, and CGCG get up some vascular defect. 
Jaffe and Lichtenstein27 suggested ABC arises 
from a pre-existing lesion of bone, frequently. 
Panoutsakopoulos et al.30 and Dal et al.31 
demonstrated that primary ABCs represent 
chromosomal translocation t (16; 17)  
(q22; p13). These findings show that the 
primary and secondary ABCs represent 
different ideas; primary ABCs getting up 
gene translocation and secondary ones 
arising from a pre-existing lesion (changes in 
vascular hemostatic balance).  
In this study, all cases with ABC except 
one case have been seen in patients under  
30 y/o and in the mandible. The other studies 
have shown somewhat similar results. In 
various studies, 90% of ABC has been reported 
in the mandible and more cases occur in the 
posterior part of the mandible.12,27,32 Results of 
Sun et al.12 from 17 patients with ABC showed 
9 patients were males and 8 were females. In 
this study, this lesion was seen in 7 males and 
5 females, and there is no significant 
difference between them. Furthermore, this 
study is consistent with previous similar 
study12 and shows approximately equal 
prevalence in two genders. 
Brown tumor with 4 cases (0.7% of all 
lesions) has been shown in this study. This non-
neoplastic lesion happened in patients with 
hyperparathyroidism, result to abnormal bone 
metabolism and local destruction. This 
condition commonly was seen in the cortical 
bone, and the mandible shows a higher 
incidence than maxilla.33,34 In this study, three 
cases of this lesion occurred in the mandible 
that confirms previous findings. 
Cherubism in recent literature reviews has 
been introduced as an autosomal dominant 
genetic disorder. In this syndrome, normal 
bone is replaced with fibrous tissue and 
cellular immature bone. The mandible is 
affected more than maxilla, usually. Other 
clinical presentation like bilateral swelling of 
the cheeks leads to ocular manifestations.35,36 
In the present study, one case of 
Cherubism was seen in the first decade and 
another case in the third decade of life that 
totally consists 0.3% of all giant cell lesions. 
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At the end, another lesion that belongs to the 
group of giant cell containing lesions is GCT. 
The GCT that occurs in the jaw bone is not 
definitely known, and there is a controversy 
about it.20 
In the present study, no case of GCT was 
observed. In this regard, many researchers 
believe that this tumor belongs to the region 
outside the jaw and basically it is 
distinguishable from the CGCG. However, 
some researchers consider this disease as a 
different appearance of one disorder.9,37 
Conclusion 
According to these results, giant cell lesions 
were more common in females and in the 
mandible. Furthermore, they occur more in 
the second decade of life. Furthermore, 
PGCG had the higher incidence rate among 
other giant cell lesions. The results can be 
useful in various fields such as oral health 
promotion programs for maintaining good 
oral health care. In conclusion, this study can 
be used and helpful as an epidemiological 
data in conjunction with other similar studies 
for giant cell lesions. 
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